What guidelines should a P & T Committee consider for the handling of cytotoxic drugs?
D000056:Accident Prevention; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D003264:Containment of Biohazards; D006801:Humans; D010606:Pharmacy and Therapeutics Committee; D012449:Safety; D014481:United States; D014489:United States Occupational Safety and Health Administration